Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vertistop® D and Vertistop® L in Preventing Recurrences of Highly Recurring BPPV
NCT05748249Phase 1Completed
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2018
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by Policlinico Gemelli. Primary endpoint: Change in the number of BPPV recurrences at 6 months. Started Nov 2018; status: completed.
Beyond the preview
Go deeper on NCT05748249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05748249.